| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 899 | 550 | 265 | 129 | 45 | 12 | 11/27/2023 | 402 | 136 |
| 899 | 550 | 265 | 129 | 45 | 12 | |||||||||
| 2 | Y | 2 SOC Chemotherapy | 159 | 102 | 49 | 26 | 7 | 1 | 11/27/2023 | |||||
| 3 SOC Chemotherapy + Durvalumab | 155 | 97 | 47 | 22 | 6 | 1 | ||||||||
| 314 | 199 | 96 | 48 | 13 | 2 | |||||||||
| S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 584 | 342 | 177 | 84 | 33 | 6 | 09/15/2023 | 420 | 159 | |
| 2 Carbo + Docetaxel + Pembro | 582 | 335 | 173 | 83 | 31 | 5 | ||||||||
| 1166 | 677 | 350 | 167 | 64 | 11 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 55 | 2 | 0 | 0 | 0 | 0 | 03/11/2021 | 449 | 190 | |
| 55 | 2 | 0 | 0 | 0 | 0 | |||||||||
| A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 47 | 30 | 10 | 2 | 1 | 1 | 08/24/2023 | 434 | 187 | ||
| 47 | 30 | 10 | 2 | 1 | 1 | |||||||||
| MA39-BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | Total Registrations | 71 | 27 | 9 | 6 | 2 | 1 | 10/18/2019 | 425 | 159 | ||
| 71 | 27 | 9 | 6 | 2 | 1 | |||||||||
| 2 | E | Total Registrations | 68 | 25 | 8 | 5 | 2 | 1 | 10/18/2019 | |||||
| 68 | 25 | 8 | 5 | 2 | 1 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 6 | 2 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | A012301-Breast, Early Stg, Tamoxifen | 1 | E | Total Registrations | 86 | 86 | 75 | 46 | 20 | 0 | 03/07/2025 | 437 | 156 | |
| 86 | 86 | 75 | 46 | 20 | 0 | |||||||||
| NRGBR007-Breast, Stg I, De-Escalation of Breast RT | 1 | E | Total Registrations | 34 | 16 | 4 | 2 | 0 | 0 | 06/01/2022 | 442 | 173 | ||
| 34 | 16 | 4 | 2 | 0 | 0 | |||||||||
| 2 | E | Total Registrations | 32 | 16 | 4 | 2 | 0 | 0 | 06/01/2022 | |||||
| 32 | 16 | 4 | 2 | 0 | 0 | |||||||||
| NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 42 | 33 | 25 | 12 | 4 | 0 | 01/31/2024 | 507 | 196 | ||
| 42 | 33 | 25 | 12 | 4 | 0 | |||||||||
| 2 | E | Total Registrations | 33 | 24 | 17 | 9 | 1 | 0 | 01/31/2024 | |||||
| 33 | 24 | 17 | 9 | 1 | 0 | |||||||||